Eli Lilly & Co (LLY)

Listed in the US · Manufacturing · Pharmaceutical preparations

$1,373.70

As of 29 Oct 2026 close.

Facts from reported results and exchange filings. Not investment advice.

Share price

Prices load here as you scroll to them.

Last close $1,373.70 on 29 Oct 2026. The share price traded between $812.25 and $1,408.38 (intraday) over the last 12 months.

The closes as a table

DateClose

Key figures

1-year range (intraday)

Last close $1,373.70

Low $812.25High $1,408.38

Market cap$1.29Tlast close × shares
P/E44.6on reported profit, last four quarters, consolidated
Net profit$27,580Mlast 12 months
Return on equity77.8%year to Dec 2025
EBITDA margin43.9%year to Dec 2025
Debt to equity1.60year to Dec 2025
Net margin31.7%year to Dec 2025
Dividend yield0.49%last 12 months

Price trend

Revenue and profit

RevenueNet profit$ million
020,00040,00060,00080,000
YearDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue28,31828,54134,12445,04365,179
Net profit5,5826,2455,24010,59020,640
EBITDA margin28.4%30.3%25.1%33.8%43.9%
Borrowings16,74116,31325,29433,81242,503

$ million. Over three years, compounded: revenue grew 31.7% a year, net profit grew 49.0% a year.

Recent filings

Questions about Eli Lilly & Co

What is Eli Lilly & Co's market value?

Eli Lilly & Co's market value is $1.29T as of 29 Oct 2026 close: the last close times the shares in issue. Its P/E is 44.6, the last close over earnings per share for the last four reported quarters.

Go further with LLY

Free to start: test a trading idea on LLY's real prices after costs, or open the full deep dive with ten years of numbers, red flags and management's record.

Same industry

The largest companies in the same industry (Pharmaceutical preparations), by market value.

Browse companies

The companies before and after this one, A to Z, and the lists it is in.

How these figures are worked out

The net profit for the last 12 months is the four latest reported quarters, so it can differ from the newest year's in the table below.